Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced Non-Small Cell Lung Cancer (NSCLC) patient - Pawel, J von; Kraff, S; Fischer, JR; Eberhardt, W; Gauler, T; Müller, L; Reinmuth, N; Reck, M; Kimmich, M; Mayer, F; Kopp, HG; Behringer, DM; Ko, YD; Frueh, M; Hilger, RA; Roessler, M; Moritz, B; Jaehde, U; Joerger, M (Pneumologie, 2016)